On July 7, 2022, Generon (Shanghai) Corporation Ltd. closed the transaction. Post the transaction, Sino Biopharmaceutical Limited and Yifan Pharmaceutical (Hong Kong) Co., Ltd. now hold 2.44% and 66.92% stakes in the company respectively.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 HKD | -0.34% | -4.25% | -15.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.56% | 6.91B | |
+39.46% | 723B | |
+34.28% | 595B | |
-4.05% | 369B | |
+20.27% | 332B | |
+2.75% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.07% | 168B |
- Stock Market
- Equities
- 1177 Stock
- News Sino Biopharmaceutical Limited
- Generon Corporation Ltd. announced that it has received $70.000203 million in funding from Sino Biopharmaceutical Limited, Yifan Pharmaceutical (Hong Kong) Co., Ltd.